West Pharmaceutical Services (WST) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $4.7 million.
- West Pharmaceutical Services' Interest & Investment Income rose 217.39% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year decrease of 2892.56%. This contributed to the annual value of $19.6 million for FY2024, which is 3000.0% down from last year.
- Per West Pharmaceutical Services' latest filing, its Interest & Investment Income stood at $4.7 million for Q3 2025, which was up 217.39% from $3.6 million recorded in Q2 2025.
- In the past 5 years, West Pharmaceutical Services' Interest & Investment Income registered a high of $9.4 million during Q4 2023, and its lowest value of $100000.0 during Q1 2021.
- For the 5-year period, West Pharmaceutical Services' Interest & Investment Income averaged around $3.5 million, with its median value being $4.0 million (2024).
- Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 8750.0% in 2021, then skyrocketed by 150000.0% in 2023.
- Over the past 5 years, West Pharmaceutical Services' Interest & Investment Income (Quarter) stood at $300000.0 in 2021, then soared by 866.67% to $2.9 million in 2022, then surged by 224.14% to $9.4 million in 2023, then tumbled by 48.94% to $4.8 million in 2024, then decreased by 2.08% to $4.7 million in 2025.
- Its Interest & Investment Income stands at $4.7 million for Q3 2025, versus $3.6 million for Q2 2025 and $4.1 million for Q1 2025.